Table 3.
Adverse Events*
| Intervention Assignment
|
|||
|---|---|---|---|
| Adverse Event | RYGB (N=20) |
LAGB (N=21) |
LWLI (N=20) |
| Serious Adverse Event | No. of patients (%) | ||
|
| |||
| Requiring Hospitalization | 0 | 2 (9.5) | 0 |
|
| |||
| Anastomotic Ulcer | 1 (5.0) | 0 | 0 |
|
| |||
| Other Adverse Event | |||
|
| |||
| Prolonged Hospital Stay (+1 night)† | 3 (15.0) | 3 (14.3) | 0 |
|
| |||
| LAGB Port Malposition | 0 | 1 (4.8) | 0 |
|
| |||
| Pruritis/Erythema at Incision Site | 0 | 1 (4.8) | 0 |
|
| |||
| Abdominal Pain | 0 | 1 (4.8) | 0 |
|
| |||
| Nausea and Emesis Requiring IV Hydration | 1 (5.0) | 0 | 0 |
*
Reflects events observed in all treated subjects regardless of follow-up status at 12-months; Patients may have had more than one event.
†
Reasons for prolonged hospital stay included elevated blood glucose, pain, and nausea prior to discharge.